Referenslitteratur för:

Referenslitteratur för Novasel TTO

 
  FÖRFATTARE OCH TIDSKRIFT
PUBLICERAD
HÄMTA PDF
       
  1. Hammer KA, Carson CF, Riley TV.
Susceptibility of transient and commensal skin flora to the essential oil of
Melaleuca alternifolia (tea tree oil).
Am J Infect Control 24:186-9; 1996.

1996 Hämta här
  2. Hammer KA, Carson CF, Riley TV.
In-vitro activity of essential oils, in particular Maelleuca alternifolia (tea tree)
oil and tea tree oil products, against Candida spp.
J Antimicrob Chemother 42: 591-5; 1998.

1998 Hämta här
  3. Saller R, Berger T, Harkenthal M.
Pharmaceutical and medicinal aspects of australian tea tree oil.
Phytomedicine  5(6):489-95; 1998.

1998  
  4. Caelli M, Porteous J, Carson CF, Heller R, Riley TV.
Tea tree oil as an alternative topical decolonization agent for
methicillin-resistent Staphylococcus aureus
J Hosp Infect 46: 236-7; 2000

2000 Hämta här
  5. Hammer KA, Carson CF, Riley TV.
In vitro activities of ketaconazole, econazole, miconazole, and Melaleuca
alternifolia (tea tree) oil against Malassezia species.
Antimicrob Agents Chemother 44:467-9; 2000.

2000
Hämta här
  6. Hammer KA, Carson CF, Riley TV.
Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by
Candida albicans.
Med Mycol 38: 355-62; 2000.

2000
Hämta här
  7. Hart PH, Brand C, Carson CF, et al.:
Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia
(tea tree oil), suppresses inflammatory mediator production by activated human monocytes.
Inflamm Res 49, 619-26; 2000.

2000 Hämta här
  8. Carson CF, Riley TV:
Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil.
Contact Dermatitis 45, 65-7, 2001.

2001 Hämta här
  9. D'Auria FD, Laino L, Strippoli V, et al.:
In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi.
J Chemother 13, 377-83; 2001.

2001 Hämta här
  10. Brand C, Grimbaldeston MA, Gamble JR et al.:
Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensivity response.
Inflamm Res 51:236-44, 2002.

2002 Hämta här
  11. Koh KJ, Pearce AL, Marshman G, et al.:
Tea tree oil reduces histamine-induced skin inflammation.
Br J Dermatol 147, 1212-7; 2002.

2002 Hämta här
  12. Satchell AC, Saurajen A, Bell C, Barnetson RS.
Treatment of dandruff with 5% tea tree oil shampoo.
J Am Acad Dermatol 47: 852-5, 2002.

2002 Hämta här
  13. Carson CF, Mee BJ, Riley TV:
Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy.
Antimicrob Agents Chemother 46, 1914-20, 2002.

2002

Hämta här
  14. Weseler A, Geiss HK, Saller R, Reichling J.
Antifungal effect of Australian tea tree oil on Malassezia pachydermatis isolated from canines suffering from cutaneous skin disease.
Schweiz Arch Tierheilkd 144: 215-21, 2002.

2002 Hämta här
  15. Hammer KA, Carson CF, Riley TV:
In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi.
J Antimicrob Chemother 50, 195-9; 2002.

2002
Hämta här
  16. Abe s, Maruyama N, Hayama K, Ishibashi H, Inoue S, Oshima H, Yamaguchi H:
Supression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils.
Mediators of Inflammation 12: 323-8; 2003.

2003 Hämta här
  17. Hammer KA, Carson CF, Riley TV.
Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil.
J Appl Microbiol 95: 853-60; 2003.

2003 Hämta här
  18. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A:
In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
J Antimicrobial Chemotherapy 51: 1223-9; 2003.

2003

Hämta här
  19. Oliva B, Piccirilli E, Ceddia T, et al.:
Antimycotic activity of Melaleuca alternifolia essential oil and its major components.
Lett Appl Microbiol 37:185-7; 2003.

2003
Hämta här
  20. Benger S, Townsend P, Ashford RL, Lambert P:
An in vitro study to determine the minimum inhibitory concentration of
Melaleuca alternifolia against the dematophyte Trichophyton rubrum.
The Foot 14: 86-91; 2004.

2004 Hämta här
  21. Calcabrini A, Stringaro A, Toccacieli L, et al.:
Terpinen-4-ol, the main component of Melaleucaalternifolia (tea tree) oil inhibits
the in vitro growth of human melanoma cells.
J Invest Dermatol 122: 349-60; 2004.

2004 Hämta här
  22. Dryden MS, Dailly S, Crouch M.
A randomized, controlled trial of tea tree topical preparations versus a standard
topical regimen for the clearance of MRSA colonization.
J Hosp Infection 56: 283-6; 2004.

2004 Hämta här
  23. Hammer KA, Carson CF, Riley TV.
Antifungal effects of Melaleuca alternifolia (tea tree) oil and its
components on Candida albicans, Candida glabrata and Saccharomyces
cerevisiae.
J Antimicrob Chemother 53: 1081-5; 2004.

2004 Hämta här
  24. Messager S, Hammer KA, Carson CF, Riely TV:
Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests.
J Hosp Infect 59: 113-25; 2005.

2005
Hämta här
 

   
  25. Messager S, Hammer KA, Carson CF, Riley TV:
Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499.
J Hosp Infect 59: 220-8; 2005.

2005 Hämta här